HN can hate me for this but I'm not taking novel not properly tested mRNA vaccine at least for another 5 years. If I remember correctly moderna's initial test vaccines caused serious liver damage in guinea pigs.
If there will be classic vaccine I'm taking it
Is it common practice to measure effectiveness in this way?
They only evaluated ~90 of their 30000 test group, and out of that tiny sliver of the data there were more in the placebo group that got covid than the vaccinated group. My questions would be:
Does their small subset have the same number of vaccinated vs placebo?
Are the ~90 evaluated cases representative of the whole group, or are they only from one area or health profile?
How long have they followed this group?
It still seems like this early on in the study you could cherry pick the data to show any amount of effectiveness that you want. Am I missing something?
6 comments
[ 2.9 ms ] story [ 23.7 ms ] threadI was going by first-posted story, which is how priority frequently (though by no means always) goes.
This story is getting frequently submitted.
Feel free to downnvote my GP top-leveel comment as I cannot edit or delete it.
They only evaluated ~90 of their 30000 test group, and out of that tiny sliver of the data there were more in the placebo group that got covid than the vaccinated group. My questions would be:
Does their small subset have the same number of vaccinated vs placebo? Are the ~90 evaluated cases representative of the whole group, or are they only from one area or health profile? How long have they followed this group?
It still seems like this early on in the study you could cherry pick the data to show any amount of effectiveness that you want. Am I missing something?